Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-214
Closed -$17K 1640
2022
Q3
$17K Sell
214
-24
-10% -$2.26K ﹤0.01% 1228
2022
Q2
$23K Buy
238
+24
+11% +$2.88K ﹤0.01% 1131
2022
Q1
$32K Hold
214
﹤0.01% 1080
2021
Q4
$30K Hold
214
﹤0.01% 1082
2021
Q3
$28K Buy
+214
New +$28K ﹤0.01% 1049

Other funds holding CNMD

Whittier Trust's CNMD Position: Q4 2022 in Review

Whittier Trust sold out of CONMED (CNMD) in Q4 2022, closing a stake of 214 shares — an estimated $17K sold.

Whittier Trust first reported a position in CNMD in Q3 2021 and held it in 5 quarters. The position peaked at $32K in Q1 2022. 239 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

  • Whittier Trust reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
  • Whittier Trust sold 214 CONMED shares in Q4 2022, an estimated $17K.
  • Whittier Trust first reported a position in CONMED in Q3 2021 and held it in 5 quarters.
  • Whittier Trust's CONMED position peaked at $32K in Q1 2022.
  • 239 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on Whittier Trust's 13F filing for Q4 2022, filed 25 Jan 2023.